Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Indivior Pharmaceuticals (INDV) Asset Utilization Ratio (2023 - 2026)

Indivior Pharmaceuticals has reported Asset Utilization Ratio over the past 4 years, most recently at 1.08 for Q1 2026.

  • For Q1 2026, Asset Utilization Ratio rose 23.82% year-over-year to 1.08; the TTM value through Mar 2026 reached 1.08, up 23.82%, while the annual FY2025 figure was 0.98, 27.37% up from the prior year.
  • Asset Utilization Ratio for Q1 2026 was 1.08 at Indivior Pharmaceuticals, up from 0.95 in the prior quarter.
  • Over five years, Asset Utilization Ratio peaked at 1.08 in Q1 2026 and troughed at 0.53 in Q1 2023.
  • A 4-year average of 0.76 and a median of 0.79 in 2024 define the central range for Asset Utilization Ratio.
  • Biggest five-year swings in Asset Utilization Ratio: soared 41.14% in 2024 and later rose 4.3% in 2025.
  • Year by year, Asset Utilization Ratio stood at 0.61 in 2023, then soared by 41.14% to 0.85 in 2024, then rose by 10.88% to 0.95 in 2025, then grew by 13.62% to 1.08 in 2026.
  • Business Quant data shows Asset Utilization Ratio for INDV at 1.08 in Q1 2026, 0.95 in Q4 2025, and 0.82 in Q3 2025.